Orville G. Kolterman
Directeur/Membre du Conseil chez American Diabetes Association Research Foundation, Inc.
Postes actifs de Orville G. Kolterman
Sociétés | Poste | Début | Fin |
---|---|---|---|
National Institute of Diabetes & Digestive & Kidney Diseases | Corporate Officer/Principal | - | - |
GlySens, Inc.
GlySens, Inc. Medical SpecialtiesHealth Technology GlySens, Inc. develops glucose monitoring system. It offers GlySens ICGM system, a long continuous glucose monitoring system intends to dramatically improve the lives of people with diabetes. The firm develops testing in clinical trials a novel, long term implant to continuously monitor and transmit blood glucose levels to smart phones and other devices. The company was founded by Joseph Y. Lucisano and David A. Gough in 1998 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 27/10/2011 | - |
American Diabetes Association Research Foundation, Inc. | Directeur/Membre du Conseil | 27/10/2011 | - |
Historique de carrière de Orville G. Kolterman
Anciens postes connus de Orville G. Kolterman
Sociétés | Poste | Début | Fin |
---|---|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - | 29/01/2019 |
University of California San Diego | Corporate Officer/Principal | 01/01/1983 | 01/01/1992 |
The University of Colorado School of Medicine | Corporate Officer/Principal | 01/01/1978 | 01/01/1983 |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | President | - | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 01/01/1992 | - |
Conseiller Juridique Général | 01/01/1992 | - |
Formation de Orville G. Kolterman
Stanford University School of Medicine | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Opérationnelle
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 6 |
---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Commercial Services |
National Institute of Diabetes & Digestive & Kidney Diseases | Government |
American Diabetes Association Research Foundation, Inc. | |
GlySens, Inc.
GlySens, Inc. Medical SpecialtiesHealth Technology GlySens, Inc. develops glucose monitoring system. It offers GlySens ICGM system, a long continuous glucose monitoring system intends to dramatically improve the lives of people with diabetes. The firm develops testing in clinical trials a novel, long term implant to continuously monitor and transmit blood glucose levels to smart phones and other devices. The company was founded by Joseph Y. Lucisano and David A. Gough in 1998 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Orville G. Kolterman
- Expérience